Brief: NovaBay Pharma CEO Issues Letter To Stockholders

Stablecoin Development

22/09/2022 21:09

Sept 22 (Reuters) - NovaBay Pharmaceuticals Inc  NBY.A :
    * NOVABAY PHARMACEUTICALS CEO ISSUES LETTER TO STOCKHOLDERS
    * NOVABAY PHARMACEUTICALS INC - IN CONNECTION WITH FINANCING
TRANSACTIONS, WE ARE REQUIRED TO SEEK STOCKHOLDER APPROVAL OF A
REVERSE STOCK SPLIT
    * NOVABAY PHARMACEUTICALS- LARGE SEASONAL ORDER FROM COSTCO
FOR
DERMADOCTOR'S TOP-SELLING PRODUCT, KAKADU C, WILL INCREASE
REVENUE IN THIRD AND FOURTH QTRS
    * NOVABAY PHARMACEUTICALS INC - BELIEVE THAT A REVERSE STOCK
SPLIT
MAY IMPROVE MARKETABILITY AND LIQUIDITY OF OUR COMMON STOCK
    * NOVABAY PHARMACEUTICALS INC- GENERALLY EXPECT A SPIKE IN
DERMADOCTOR SALES DURING FALL
    * NOVABAY PHARMACEUTICALS INC- EXPECT CONTINUED GROWTH
THROUGH
2022 AND INTO 2023

Source text for Eikon:  ID:nBw53SpFTa 
Further company coverage:  NBY.A 
 ((Reuters.Briefs@thomsonreuters.com;))